Recalls
When a product is unsafe or breaks the rules, the company pulls it back and FDA classes the recall. Class I could cause serious harm or death. Class II could cause temporary harm. Class III is unlikely to hurt anyone.
5,412 recalls in the last 12 months. Newest first.
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Dec 10, 2025 | Class II | Philips North America Llc Device |
IntelliVue MP30. Product Number: M8002A. Potential issue where the IntelliVue monitors did not alarm. FDA notice Z-0852-2026 |
| Dec 10, 2025 | Class II | GET TESTED INTERNATIONAL AB Device |
Food Intolerance Test Small Distribution without premarket approval/clearance. FDA notice Z-0808-2026 |
| Dec 10, 2025 | Class II | Philips North America Llc Device |
IntelliVue MP90. Product Number: M8010A. Potential issue where the IntelliVue monitors did not alarm. FDA notice Z-0858-2026 |
| Dec 3, 2025 | Class II | Homeneeds Inc Food |
DEVI brand Cinnamon Powder (Dalchini Powder), net wt.: 3.5 oz (100 g), packaged in flexible plastic bag. UPC 6 09595 11904 5. Imported and Distributed by Homeneeds Inc. Bellevue, WA 98007; Product of India Elevated levels of lead. FDA ground cinnamon sample was found to contain 2.92 mg/kg. FDA notice H-0208-2026 |
| Dec 3, 2025 | Class I | WFM Purchasing, LP Food |
Whatcom Farmhouse- Sliced and packaged in deli plastic wrap with Whole Foods Scale labels. Twin Sisters Creamery's recall of cheese products due to WSDA testing that identified potential STEC and E. coli O103 contamination. Whole Foods Market received affected products through distributor Peterson Company and sold them by weight with store-generated labels. FDA notice H-0211-2026 |
| Dec 3, 2025 | Class I | MeriCal, LLC Food |
Member's Mark Super Greens Dietary Supplement; 48 servings; Net Weight 18.28 oz (518.4g) UPC: 193968490775 Potential contamination of Salmonella Richmond FDA notice H-0205-2026 |
| Dec 3, 2025 | Class II | Jeni's Splendid Ice Creams LLC Food |
Jeni's Passion Fruit Dreamsicle Ice Cream Bars, 3 FL OZ (89 ML)/9 FL OZ (266 ML), packaged 3 bars per retail carton with Item UPC: 850060644122, packed 8 retail cartons per case with Case UPC: 10850060644129 Undeclared allergens - wheat and soy FDA notice H-0207-2026 |
| Dec 3, 2025 | Class I | FRC INC Food |
Face Rock Creamery Vampire Slayer Garlic Cheddar, net wt. 6oz. Ready to Eat, Refrigerated/ Perishable. Product is packaged in sealed in bag and shrink dipped. UPC 8 51222 00547 8. Face Rock Creamery, 680 2nd St. SE Bando… FDA environmental sample identified the presence of Listeria monocytogenes in the processing area where cheese was packaged. FDA notice H-0212-2026 |
| Dec 3, 2025 | Class II | Nats Nuts LLC Food |
Nat's Nuts Cinnamon Whiskey Pecans, 4 oz. Contains undeclared cashews FDA notice H-0206-2026 |
| Dec 3, 2025 | Class I | WFM Purchasing, LP Food |
Whatcom Blue Sliced cheese; Sliced and packaged in deli plastic wrap with Whole Foods Scale labels. Twin Sisters Creamery's recall of cheese products due to WSDA testing that identified potential STEC and E. coli O103 contamination. Whole Foods Market received affected products through distributor Peterson Company and sold them by weight with store-generated labels. FDA notice H-0210-2026 |
| Dec 3, 2025 | Class II | CA BOTANA International, Inc. Drug |
Dr. Bump Natural Pain Relief Gel, Menthol 5%, NET WT 4 FL OZ/118 ML per bottle, Distr. by 1Beauty US LLC, Palm Desert, CA 92211. NDC: 35192-052-18, UPC 8 18204 02513 8 CGMP Deviations FDA notice D-0196-2026 |
| Dec 3, 2025 | Class II | Medical Products Laboratories, Inc. Drug |
Walgreens Saline Nasal Spray WITH XYLITOL, 1.5 oz (45mL) bottle, DISTRIBUTED BY: WALGREEN CO., 200 WILMOT RD., DEERFIELD, IL 60015, NDC 0363-3114-01 Microbial contamination of a non-sterile product - microorganism found to be pseudomonas lactis FDA notice D-0179-2026 |
| Dec 3, 2025 | Class II | CA BOTANA International, Inc. Drug |
Gabriel Mineral Sunscreen SPF 50, Zinc Oxide 21%, 2.1 oz, Net 61 g per tube, Dist. By: Gabriel Cosmetics, Inc., Redmond, WA USA 98052, NDC: 35192-044-01, UPC 7 07060 9592 1 CGMP Deviations FDA notice D-0190-2026 |
| Dec 3, 2025 | Class II | CA BOTANA International, Inc. Drug |
Doctor D. Schwab Flawless Skin Fluid Tinted Moisturizer SPF 50, Zinc Oxide 21%, 2.1 oz/61 g per tube, Manufactured by CA BOTANA, San Diego, CA 92121. NDC: 35192-043-17 CGMP Deviations FDA notice D-0184-2026 |
| Dec 3, 2025 | Class II | CA BOTANA International, Inc. Drug |
Elixir by Coco March Mineral Sunscreen SPF 50, Zinc Oxide 21%, 2.1 oz (62g) per bottle, Distributed by: VitaTienda Co U.S.A., San Juan, PR 00646. NDC: 35192-048-17, UPC 8 10145 82007 0 CGMP Deviations FDA notice D-0193-2026 |
| Dec 3, 2025 | Class II | CA BOTANA International, Inc. Drug |
Sea Enzyme Ultra Umbrella Sunscreen SPF 30, Titanium Dioxide 4%, Octinoxate 4%, 4 oz./113.4 g per tube, Manufactured by CA BOTANA, San Diego, CA 92121. NDC: 35192-011-02 CGMP Deviations FDA notice D-0187-2026 |
| Dec 3, 2025 | Class II | CA BOTANA International, Inc. Drug |
Doctor D. Schwab Clinical Weh Weh Natural Pain Relief Gel with Menthol and Arnica, Menthol 5%, 4.2 oz./120 g per tube, Doctor D. Schwab, A division of CA BOTANA, San Diego, CA 92121. NDC: 35192-020-02 CGMP Deviations FDA notice D-0188-2026 |
| Dec 3, 2025 | Class II | CA BOTANA International, Inc. Drug |
CLEARSTEM YOU ARE SUNSHINE SPF 50, Zinc Oxide 21%, 2.1 oz/61g per bottle, Distributed by: CLEARSTEM Skincare, clearstemskincare.com. NDC: 35192-046-17 CGMP Deviations FDA notice D-0195-2026 |
| Dec 3, 2025 | Class II | CA BOTANA International, Inc. Drug |
Doctor. D. Schwab Mineral Sunscreen SPF 50, Zinc Oxide 21%, 4 oz./ 113.4 g per tube, Manufactured by CA Botana, San Diego, CA 92123. NDC: 35192-042-02 CGMP Deviations FDA notice D-0183-2026 |
| Dec 3, 2025 | Class II | CA BOTANA International, Inc. Drug |
Doctor D. Schwab Shimmery Sun Lotion Sunscreen SPF 30, Titanium Dioxide 5% and Octinoxate 4%, 4 oz./113.4 g per tube, Doctor D. Schwab, A division of CA BOTANA, San Diego, CA 92121. NDC: 35192-012-02 CGMP Deviations FDA notice D-0189-2026 |
| Dec 3, 2025 | Class II | CA BOTANA International, Inc. Drug |
Doctor D. Schwab Controlling Balm with Tea Tree Oil, Salicyclic Acid 0.8%, 1 FL OZ/ 30 ML per tube, Doctor D. Schwab, A division of CA BOTANA, San Diego, CA 92123. NDC: 35192-016-05 CGMP Deviations FDA notice D-0185-2026 |
| Dec 3, 2025 | Class I | Fresenius Kabi USA, LLC Drug |
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale). Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing. FDA notice D-0182-2026 |
| Dec 3, 2025 | Class II | CA BOTANA International, Inc. Drug |
Doctor D. Schwab Controlling Cream, Benzoyl Peroxide 2.7%, 1 FL OZ/ 30 ML per tube, Doctor D. Schwab, A division of CA BOTANA, San Diego, CA 92123. NDC: 35192-017-05 CGMP Deviations FDA notice D-0186-2026 |
| Dec 3, 2025 | Class II | CA BOTANA International, Inc. Drug |
Sugared+Bronzed Tinted Mineral Sunscreen SPF 50, Zinc Oxide 21%, Net WT 3.3 OZ (93 G) per tube, Dist. By: Sugared+Bronzed, 929 Montana Ave, Santa Monica, CA 90403. NDC: 35192-055-18, UPC 8 50047 92223 6 CGMP Deviations FDA notice D-0192-2026 |
| Dec 3, 2025 | Class II | CA BOTANA International, Inc. Drug |
Elixir by Coco March Tinted Mineral Sunscreen SPF 50, Zinc Oxide 21%, 2.1 oz (62g) per bottle, Distributed by: VitaTienda Co U.S.A., San Juan, PR 00646. NDC: 35192-050-17, UPC 6 7229 99913 8 CGMP Deviations FDA notice D-0194-2026 |
| Dec 3, 2025 | Class II | CA BOTANA International, Inc. Drug |
Karina Daily Moisturizer SPF 25, Octinoxate 7.5% and Zinc Oxide 7.0%, Net WT. 5 oz/ 141.7 g per tube, Dist. By: Beauty4Pros LLC, Palm Desert, CA 92211. NDC: 35192-033-16, UPC 8 18204 02572 5 CGMP Deviations FDA notice D-0191-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
Outlook set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with corresponding… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0708-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0660-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0645-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
Extension Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with correspondi… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0628-2026 |
| Dec 3, 2025 | Class II | Remel, Inc Device |
1. CAMHB W/LHB, MANUAL, 11ML, 10/BOX YCP112-10 2. BRUCELLA BROTH, 11ML, 10/BOX YT3450 Products may contain contamination, which may result in a darker or brown media color. FDA notice Z-0585-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
Anesthesia IV Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with corresp… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0609-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
B.BRAUN utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with corresponding cat… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0615-2026 |
| Dec 3, 2025 | Class II | Stryker Corporation Device |
NICO Myriad Illumination Pack Product No. NN-1000 11g Illumination Sleeve/Fiber; Product No. NN-1001 13g Illumination Sleeve/Fiber Tape used to secure components within packaging contains latex, despite products being labeled as latex-free. Latex could potentially cause an allergic reaction. FDA notice Z-0600-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0697-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0702-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0649-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0691-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0655-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
SafeDAY set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with corresponding… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0711-2026 |
| Dec 3, 2025 | Class II | Pivotal Health Solutions, Inc. Device |
Quantum Intersegmental Table, Model/Catalog Number: AMQ400H; heated massage table The heat function may become damaged over time due to patients pressing on the areas with heat function components. Damage to components can lead to overheating which can lead to smoldering and melting of the vinyl cushion. FDA notice Z-0588-2026 |
| Dec 3, 2025 | Class II | PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. Device |
Philips Azurion 7M20 systems with FlexArm ceiling-mounted system. Model Number: 722234; The motorized longitudinal movement of the FlexArm stand may be inconsistent (not smooth) and eventually may become unavailable. This issue is due to grease leakage from the bearings and/or anti-corrosion oil applied on the bearings, because of which the lubrication on the ceiling rail may be excessive, reducing the friction between the rails and the friction wheel. Expansion to add additional model. FDA notice Z-0719-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
Blood Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with … Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0619-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0717-2026 |
| Dec 3, 2025 | Class II | Inpeco S.A. Device |
FlexLab (FLX); Version: FLX-217-10; The Aliquoter Module (mALX) may generate secondary sample tubes without labels or with mismatched labels which may result in delayed results or erroneous results. This error occurs if the operators open the printer head of mALX to perform error recoveries or maintenance procedures and do not empty the printer tubes buffer to remove all the secondary sample tubes. FDA notice Z-0595-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
Extension Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with correspondi… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0630-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
Burette Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with corresponding… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0622-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
CARESAFE utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with corresponding ca… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0623-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
IV Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with cor… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0648-2026 |
| Dec 3, 2025 | Class II | B Braun Medical Inc Device |
ULTRASITE set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Large Volume Pump, Outlook Pump, and Vista Basic Pump. Labeled as the following with correspondi… Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion). FDA notice Z-0714-2026 |